1,872
Views
14
CrossRef citations to date
0
Altmetric
Research Papers

Significant transcriptome and cytokine changes in hepatitis B vaccine non-responders revealed by genome-wide comparative analysis

ORCID Icon, , , , , , , , , & show all
Pages 1763-1772 | Received 05 Dec 2017, Accepted 02 Mar 2018, Published online: 14 May 2018
 

ABSTRACT

Individuals fail to elicit protective antibody after hepatitis B vaccination remain at risk for hepatitis B virus infection. Analysis of the transcriptome of peripheral blood mononuclear cells (PBMCs) is essential to elucidate the characteristics of gene expression in non-responders. In this study, we enrolled seven responders who had received three injections and seven non-responders who had six injections of hepatitis B vaccine before. All the participants were then vaccinated with a three-dose boost regimen. Microarray analysis and Luminex assay were applied to examine mRNA expression and Th1/Th2/Th9/Th17/Th22/Treg cytokine and chemokine profiles in non-responders and responders. Differentially expressed genes in PBMCs of non-responders at 5 time points, i.e. pre-vaccination, 3rd, 7th, 28th day post the first dose vaccination and 7th day post the second dose vaccination indicated a dense network trend. Compared with responders, nine coding genes (BPI, DEFA1B, DEFA4, CEACAM8, MMP8, FOLR3, LTF, TCN1 and TKTL1) were significantly up-regulated in non-responders at all 5 time points, which could probably be the characteristic genes in hepatitis B vaccine non-responsiveness. Gene ontology analysis revealed that most of the DEGs were related with immune responses. Validation results of these 9 genes using quantitative real-time polymerase chain reaction were mostly consistent with the results of microarray. Cytokine analysis demonstrated that IL-27 and CXCL12 concentrations in responders were significantly higher than non-responders on the 3rd day after the first dose and 7th day after the second dose of vaccination, respectively. No significant difference was observed in other cytokine and chemokine signatures between the two groups. In conclusion, our results revealed characteristic transcriptome and cytokine changes in hepatitis B vaccine non-responders after boost immunization.

Abbreviations

PBMC=

Peripheral blood mononuclear cell

HB=

Hepatitis B

HLA=

Human leukocyte antigens

HBsAg=

Hepatitis B surface antigen

GO=

Gene Ontology

IL=

Interleukin

IFNG=

Interferon-γ

BPI=

Bactericidal/ permeability-increasing protein

CEACAM8=

Carcinoembryonic antigen related cell adhesion molecule 8

DEFA4=

Defensin alpha 4

LTF=

Lactotransferrin

MMP8=

Matrix metallopeptidase 8

RNASE3=

Ribonuclease A family member 3

FOLR3=

Folate receptor 3

TCN1=

Transcobalamin 1

TKTL1=

Transketolase like 1

RMA=

Robust multichip analysis

qRT-PCR=

Real-time quantitative polymerase chain reaction

Disclosure potential conflicts of interest

The authors declare no conflict of interest.

Acknowledgments

We thank relevant personnel from Zhangqiu Center for Disease Control and Prevention of Shandong province for their contribution in blood sample collection.

Additional information

Funding

This work was supported by the National Science and Technology Major Projects on “Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment” under Grant #2012ZX10004701 from the Ministry of Science and Technology of the People's Republic of China.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.